| Literature DB >> 32437627 |
Lauren G Douma1, G Ryan Crislip1, Kit-Yan Cheng1, Dominique Barral1, Sarah Masten1, Meaghan Holzworth1, Emilio Roig1, Krystal Glasford1, Kevin Beguiristain1, Wendy Li1, Phillip Bratanatawira1, I Jeanette Lynch1,2, Brian D Cain3, Charles S Wingo1,2, Michelle L Gumz1,3,2.
Abstract
Previously, we showed that global knockout (KO) of the circadian clock transcription factor PER1 in male, but not female, mice fed a high-salt diet plus mineralocorticoid treatment (HS/DOCP) resulted in nondipping hypertension and decreased night/day ratio of sodium (Na) excretion. Additionally, we have shown that the endothelin-1 (ET-1) gene is targeted by both PER1 and aldosterone. We hypothesized that ET-1 would exhibit a sex-specific response to HS/DOCP treatment in PER1 KO. Here we show that male, but not female, global PER1 KO mice exhibit a decreased night/day ratio of urinary ET-1. Gene expression analysis revealed significant genotype differences in ET-1 and endothelin A receptor (ETA) expression in male, but not female, mice in response to HS/DOCP. Additionally, both wild-type and global PER1 KO male mice significantly increase endothelin B receptor (ETB) expression in response to HS/DOCP, but female mice do not. Finally, siRNA-mediated knockdown of PER1 in mouse cortical collecting duct cells (mpkCCDc14) resulted in increased ET-1 mRNA expression and peptide secretion in response to aldosterone treatment. These data suggest that PER1 is a negative regulator of ET-1 expression in response to HS/DOCP, revealing a novel mechanism for the regulation of renal Na handling in response to HS/DOCP treatment.Entities:
Keywords: aldosterone; aldostérone; endothelin; endothéline; hypertension sans abaissement nocturne; kidney; nondipping hypertension; rein; renal sodium handling; régulation rénale du sodium
Mesh:
Substances:
Year: 2020 PMID: 32437627 PMCID: PMC7605171 DOI: 10.1139/cjpp-2019-0688
Source DB: PubMed Journal: Can J Physiol Pharmacol ISSN: 0008-4212 Impact factor: 2.273